>AT4G34540.1 |  isoflavone reductase family protein 
MEEEKKKSRVLIIGATGRLGNYLTRFSIESGHPTFALIRNTTLSDKLKSLSDAGVTLLKG 
SLEDEGSLAEAVSKVDVVISAIPSKHVLDQKLLVRVIKQAGSIKRFIPAEYGANPDKTQV 
SDLDHDFYSKKSEIRHMIESEGIPYTYICCGLFMRVLLPSLVQPGLQSPPTDKVTVFGDG 
NVKAVFVNDVDVAAFTIKTIDDPRTLNKTLYLSPPGNICSMNDLVELWEGKIEKKLEKTF 
ATENQLLKKIKETPYPDNMEMVFIYSVFIKGDHTYFDIESCGGVNGTELYPDVKYMTVSE 
FLDTLL*
>AT1G34420.1 |  leucine-rich repeat family protein / protein kinase family protein 
MFTGVKKMKKIHVPPETGKFMFCLFFSFLSCCHVCFSELSLNQTNTMIELSSFLNISDWN 
LPGSERNPCSWNGVLCSLPDNSSVISLSLSNFDLSNSSFLPLVCNLQTLESLDVSNNRLS 
SIPEGFVTNCERLIALKHLNFSTNKFSTSPGFRGFSKLAVLDFSHNVLSGNVGDYGFDGL 
VQLRSLNLSFNRLTGSVPVHLTKSLEKLEVSDNSLSGTIPEGIKDYQELTLIDLSDNQLN 
GSIPSSLGNLSKLESLLLSNNYLSGLIPESLSSIQTLRRFAANRNRFTGEIPSGLTKHLE 
NLDLSFNSLAGSIPGDLLSQLKLVSVDLSSNQLVGWIPQSISSSLVRLRLGSNKLTGSVP 
SVAFESLQLLTYLEMDNNSLTGFIPPSFGNLVSLNLLNLAMNEFTGILPPAFGNLSRLQV 
IKLQQNKLTGEIPDTIAFLSNLLILNISCNSLSGSIPPSLSQLKRLSNMNLQGNNLNGTI 
PDNIQNLEDLIELQLGQNQLRGRIPVMPRKLQISLNLSYNLFEGSIPTTLSELDRLEVLD 
LSNNNFSGEIPNFLSRLMSLTQLILSNNQLTGNIPRFTHNVSVDVRGNPGVKLKTENEVS 
IQRNPSGKSKLVMIVIFVSLGVLALLTGIITVTVLKFSRRCKGINNMQVDPDEEGSTVLP 
EVIHGKLLTSNALHRSNINFAKAVEAVAHPEHGLHQTMFWSYYRVVMPSGSSYFIKKLNT 
RDRVFQQASSEQLEVELEMLGKLHHTNVMVPLAYVLYSEGCLLIYDFSHTCTLYEILHNH 
SSGVVDWTSRYSIAVGIAQGISYLHGSESSGRDPILLPDLSSKKILLKSLTEPLVGDIEL 
FKVIDPSKSNSSLSAVAGTIGYIPPEYAYTMRVTMAGNVYSFGVILLELLTGRPAVSEGR 
DLAKWVQSHSSHQEQQNNILDLRVSKTSTVATKQMLRALGVALACINISPGARPKMKTVL 
RMLTRL*
>AT5G24670.1 |  catalytic/ hydrolase/ zinc ion binding 
MDSDAWEIIHIPEKPSLSPDHQPTVKVYASLIKPRFANTIVRHLCKIAPLEDLRHVKRVK 
KKILPDCGETQLTVILCLAPEHNDQLSDMPPDVQRLVDPYELSPFITQVCKYAAVSKEEW 
EEQSKIWPTSFHPPTYNIDGIGGFSEEETQSICKFMRVVIDMAVSGHTPLVNAAVIVDPS 
VRRIIASETDQVYASSAPRDMTSAETRPFEETGEICLNDTLEKQNGSLSALSCLNPWQWS 
LQPHDTENCSQWHPLRHASMVAIESSSARDRNLFPNPSKIFDQDHVPPSNTDSPAKKQKT 
SSQSPDVQNDSREETVRDPSMERPYLCTGYDIFLLLEPCTMCAMALVHQRIKRIFYAFPN 
TTAGGLGSVHRLQGEKSLNHHYAVFRVLLPDDALRQMTTV*
>AT5G49660.1 |  leucine-rich repeat transmembrane protein kinase putative 
MRLKNFPFFVLFFFFCFNSNQSWGLMSSNQQPQFFKLMKNSLFGDALSTWNVYDVGTNYC 
NFTGVRCDGQGLVTDLDLSGLSLSGIFPDGVCSYFPNLRVLRLSHNHLNKSSSFLNTIPN 
CSLLRDLNMSSVYLKGTLPDFSQMKSLRVIDMSWNHFTGSFPLSIFNLTDLEYLNFNENP 
ELDLWTLPDSVSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVDLELSGNFLSGEIPKEIG 
NLSNLRQLELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGSIPDSICSLPNLRVLQLY 
NNSLTGEIPKSLGNSKTLKILSLYDNYLTGELPPNLGSSSPMIALDVSENRLSGPLPAHV 
CKSGKLLYFLVLQNRFTGSIPETYGSCKTLIRFRVASNRLVGTIPQGVMSLPHVSIIDLA 
YNSLSGPIPNAIGNAWNLSELFMQSNRISGVIPHELSHSTNLVKLDLSNNQLSGPIPSEV 
GRLRKLNLLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENLSELLPTSINFSS 
NRLSGPIPVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAILVS 
VFILVLGVIMFYLRQRMSKNRAVIEQDETLASSFFSYDVKSFHRISFDQREILESLVDKN 
IVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASEDKMHLNKELKTEVETLGSIRHKN 
IVKLFSYFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWRTRHQIAVGVAQGLAYLHHDL 
SPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPEYAYSS 
KATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSES 
SKADMINALRVAIRCTSRTPTIRPTMNEVVQLLIDATPQGGPDMTSKPTTKIKDSIVSDH 
LTQTRL*
>AT5G62230.1 |  ERL1 (ERECTA-LIKE 1) kinase 
MKEKMQRMVLSLAMVGFMVFGVASAMNNEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCS 
WRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCAS 
LVYLDLSENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLT 
GEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTS 
FQILDISYNQITGEIPYNIGFLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVG 
PIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQL 
FELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKG 
KIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSI 
QMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSG 
IVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIF 
LAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASS 
TVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLF 
YDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNIL 
LDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLL 
ELLTGKKAVDNEANLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQLALLCTKRN 
PLERPTMLEVSRVLLSLVPSLQVAKKLPSLDHSTKKLQQENEVRNPDAEASQWFVQFREV 
ISKSSI*